Since we have demonstrated that ADAM9 functions at the early stages of virus infection (Fig. 2), we next investigated whether the protease activity of ADAM9 participates in SARS-CoV-2 Spike Vpp binding or endocytosis. This evidence concerns the gene CHMP5 and viral infectious disease.